SR419

· Shanghai SIMR Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SR419, covering 2024-01-05 to 2025-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 [Phase 1, Phase 2]